Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT03364673

NCT03364673
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have been recently diagnosed with ovarian cancer
  • You finished chemotherapy no more than 6 months ago
  • You are able to read English
  • You do not have any thinking, vision, or physical/movement difficulties that would stop you from taking part
  • You plan to keep receiving your treatment at Dana-Farber Cancer Institute

Who may not be able to join:

  • You are already taking part in another health or wellness program that uses a mobile phone app or digital device
  • You are not able to walk independently
  • You do not own a smartphone that could be used to send data from a fitness tracker or wearable device

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Dana-Farber Cancer Institute
Registry
clinicaltrials_gov
Start date
20 July 2018
Est. completion
31 October 2019

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of the Accelerometer + Social Support + Gamification; Acceptability; Perceived Effectiveness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov